Home/ Supplements/ Alpha Lipoic Acid/ Skin Support Pack

Skin Support Pack

product on market Other (e.g. tea bag) Douglas Laboratories Safety: 89/100
89/100

This product is generally safe

  • Niacin/Niacinamide: 47.5mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • B. bifidum: 275000000mg is 13750000.0× the Tolerable Upper Intake Level (20mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 36% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The listed ingredients consist of macronutrients, specifically various types of fats, which provide essential energy and structural components for skin health. There is strong evidence supporting the role of polyunsaturated and monounsaturated fats in maintaining the skin barrier. However, the overall evidence coverage for this specific formulation is very limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin/Niacinamide: 47.5mg is 1.4× the Tolerable Upper Intake Level (35mg)

B. bifidum: 275000000mg is 13750000.0× the Tolerable Upper Intake Level (20mg)

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Skin Support Pack
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Packet(s)
Serving Size
30
Servings
Other Combinations
Product Type
36%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
4.5 {Calories}
Calories from Fat
4.5 {Calories}
Saturated Fat
0.04 g (1% DV)
Polyunsaturated Fat
0.4 g
Monounsaturated Fat
0.06 g
Vitamin A
3750 IU (75% DV)
1150 mg (1917% DV)
12.8× RDA — above typical dose (UL: 2000 mg) 250 studies (A:6, B:97)
500 IU (125% DV)
Within RDA (0.8× RDA) 608 studies (A:16, B:251)
500 IU (1667% DV)
22.3× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
25 mg (1667% DV)
20.8× RDA — above typical dose 76 studies (A:0, B:33)
12.5 mg (765% DV)
9.6× RDA — above typical dose 13 studies (A:0, B:1)
47.5 mg (240% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)
Vitamin B-6 Complex
25 mg (1250% DV)
200 mcg (50% DV)
Within RDA (0.5× RDA) 226 studies (A:10, B:105)
62.5 mcg (1041% DV)
26.0× RDA — above typical dose 139 studies (A:1, B:44)
75 mcg (25% DV)
2.5× RDA — within safe limits 27 studies (A:0, B:11)
125 mg (1250% DV)
25.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
125 mg (13% DV)
50 mcg (33% DV)
Within RDA (0.3× RDA) 245 studies (A:4, B:133)
125 mg (31% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
6 mg (40% DV)
Within RDA (0.5× RDA) 263 studies (A:6, B:134)
50 mcg (71% DV)
Within RDA (0.9× RDA) 173 studies (A:0, B:67)
0.5 mg (25% DV)
Within RDA (0.6× RDA) 37 studies (A:0, B:11)
2.5 mg (125% DV)
1.1× RDA — within safe limits 9 studies — no high-quality reviews
50 mcg (42% DV)
1.4× RDA — within safe limits 199 studies (A:1, B:55)
25 mcg (33% DV)
Within RDA (0.6× RDA) 3 studies — no high-quality reviews
Potassium
25 mg (1% DV)
L. acidophilus
1150000000 CFU
L. rhamnosus
1150000000 CFU
L. Rhamnosus
775000000 CFU
S. Lactis
275000000 CFU
275000000 CFU
Market median: 80.0mg (20 products) 337 studies (A:8, B:183)
275000000 CFU
Exceeds UL by 13750000.0× (UL: 20 mg) 3 studies — no high-quality reviews
S. thermophilus
150000000 CFU
Proprietary Blend
215 mg
organic cold-pressed Oil of Evening Primrose
500 mg
400 mg
Market median: 500.0mg (159 products)
Proprietary Organic Fruit and Vegetable Blend
175 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
L-Proline
80 mg
Blackberry
40 mg
L-Cysteine/N-Acetyl L-Cysteine
38 mg
29 mg
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Celery powder
35 mg
Black Radish Powder
35 mg
Apricot powder
35 mg
Pycnogenol
25 mg
1.7× RDA — within safe limits 179 studies (A:3, B:90)
25 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Cauliflower
25 mg
25 mg
Market median: 200.0mg (107 products)
25 mg
Market median: 4.0mg (67 products)
Green Papaya extract
25 mg
Rose Hips
25 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
25 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
15 mg
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Apple Pectin
12.5 mg
12.5 mg
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
12.5 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
Hesperidin
9 mg
7.5 mg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
6 mg
Market median: 500.0mg (19 products)
Glutamic Acid
5 mg
Market median: 500.0mg (193 products) 7 studies — no high-quality reviews
1.6 mg
Market median: 4.0mg (32 products)
1.5 mg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)
0.4 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
Trace Elements
25 mcg
13 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)

Other Ingredients

Gelatin Cellulose Vegetable Stearate L-Threonine Silica Glycerin Water Rosemary extract Mixed Tocopherols Ascorbyl Palmitate Citric Acid Safflower Oil
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, adults take 1 pack daily with meals or as directed by your healthcare professional.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Tamper resistant package, do not use if outer seal is missing.

Formulation Notes

This product contains NO yeast, soy protein, milk/dairy, sodium, starch, artificial coloring, preservatives or flavoring.

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

FloraGlo(R) LUTEIN

PYCNOGENOL(R) (pine trees) NATURE'S SUPER ANTIOXIDANT FloraGLO(R) LUTEIN

Formula #65383

Metadata

Product Details

UPC / SKU3 10539 03549 8
DSLD Entry Date2012-06-01
Product TypeOther Combinations
FormOther (e.g. tea bag)
DSLD ID9641
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.